Neutrophil-lymphocyte ratio as a predictive marker for progression free survival in patients with advanced cutaneous squamous cell carcinoma prior to Cemiplimab treatment – a real-life setting
Irina Ciobotariu(Università Cattolica del Sacro Cuore), Ketty Peris(Università Cattolica del Sacro Cuore), Alessandro Di Stefani(University of Rome Tor Vergata), Lucia Di Nardo(Università Cattolica del Sacro Cuore), Andrea Paradisi(Università Cattolica del Sacro Cuore)
Cited by 2
Related Papers
Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines
|European Journal of Cancer|2019|589
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment
|European Journal of Cancer|2020|324
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022
|European Journal of Cancer|2022|320
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022
|European Journal of Cancer|2022|287
Understanding the Molecular Genetics of Basal Cell Carcinoma
|International Journal of Molecular Sciences|2017|243